申请人:GLAXOSMITHKLINE LLC
公开号:WO2013066836A1
公开(公告)日:2013-05-10
The present invention relates to compounds that inhibit histone deacetylase (HDAC) enzymes, the preparation of these compounds or salts of said compound, the use of these compounds in the treatment of neurodegenerative diseases or conditions ameliorated by inhibition of HDAC activity and pharmaceutical compositions that are comprised of these compounds.
本发明涉及抑制组蛋白去乙酰化酶(HDAC)酶的化合物,这些化合物或该化合物的盐的制备,这些化合物在治疗神经退行性疾病或通过抑制HDAC活性改善的病症中的使用,以及由这些化合物组成的药物组合物。